Y-Biologics to continue antibody drug development through IPO - KBR
| PYSIX Fund | USD 9.65 0.02 0.21% |
Slightly above 55% of Payden Strategic's investor base is interested to short. The analysis of overall sentiment of trading Payden Strategic Income mutual fund suggests that many investors are impartial at this time. Payden Strategic's investing sentiment can be driven by a variety of factors including economic data, Payden Strategic's earnings reports, geopolitical events, and overall market trends.
Payden |
Y-Biologics to continue antibody drug development through IPO KBR
Read at news.google.com
 |
Payden Strategic Fundamental Analysis
We analyze Payden Strategic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Payden Strategic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Payden Strategic based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Payden Strategic is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Payden Strategic Income Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Payden Strategic mutual fund to make a market-neutral strategy. Peer analysis of Payden Strategic could also be used in its relative valuation, which is a method of valuing Payden Strategic by comparing valuation metrics with similar companies.
Peers
Payden Strategic Related Equities
| PGKCX | Pgim Jennison | 1.03 | ||||
| DTGRX | Dreyfus Technology | 1.01 | ||||
| CMTFX | Columbia Global | 0.99 | ||||
| VITAX | Vanguard Information | 0.95 | ||||
| ITYYX | Invesco Technology | 0.88 | ||||
| ROGSX | Red Oak | 0.74 | ||||
| HTECX | Hennessy Technology | 0.55 |
Other Information on Investing in Payden Mutual Fund
Payden Strategic financial ratios help investors to determine whether Payden Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Payden with respect to the benefits of owning Payden Strategic security.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |